Cerebral Angiography Market by Product (Computed Tomography Angiography, Magnetic Resonance Angiography, X-ray Angiography), Route of Administration (Transfemoral, Transradial), Application, End-User - Global Forecast 2024-2030

Cerebral Angiography Market by Product (Computed Tomography Angiography, Magnetic Resonance Angiography, X-ray Angiography), Route of Administration (Transfemoral, Transradial), Application, End-User - Global Forecast 2024-2030


The Cerebral Angiography Market size was estimated at USD 1.41 billion in 2023 and expected to reach USD 1.51 billion in 2024, at a CAGR 6.85% to reach USD 2.25 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cerebral Angiography Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cerebral Angiography Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cerebral Angiography Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health, Inc., Carestream Health, Inc., Cook Group Incorporated, GE Healthcare Technologies Inc., Hitachi Medical Corporation, Hologic, Inc., InterMed Medical Limited, Koninklijke Philips N.V., MEDTRON AG, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Samsung Medison Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, St. Stone Medical Devices Private Limited, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage


This research report categorizes the Cerebral Angiography Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Computed Tomography Angiography
Magnetic Resonance Angiography
X-ray Angiography
Route of Administration
Transfemoral
Transradial
Application
Diagnostics
Therapeutics
End-User
Ambulatory Surgical Centers
Hospitals & Clinics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cerebral Angiography Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cerebral Angiography Market?
3. What are the technology trends and regulatory frameworks in the Cerebral Angiography Market?
4. What is the market share of the leading vendors in the Cerebral Angiography Market?
5. Which modes and strategic moves are suitable for entering the Cerebral Angiography Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cerebral Angiography Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of cerebrovascular diseases and injuries
5.1.1.2. Preference for minimally invasive and image-guided surgeries
5.1.1.3. Initiatives to raise awareness and early diagnosis of brain disorders
5.1.2. Restraints
5.1.2.1. Complex reimbursement for angiography procedures
5.1.3. Opportunities
5.1.3.1. Technological advancements in cerebral angiography
5.1.3.2. Expanding demand for hybrid angiography imaging systems
5.1.4. Challenges
5.1.4.1. Potential side effects of undergoing cerebral angiography
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cerebral Angiography Market, by Product
6.1. Introduction
6.2. Computed Tomography Angiography
6.3. Magnetic Resonance Angiography
6.4. X-ray Angiography
7. Cerebral Angiography Market, by Route of Administration
7.1. Introduction
7.2. Transfemoral
7.3. Transradial
8. Cerebral Angiography Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Therapeutics
9. Cerebral Angiography Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals & Clinics
10. Americas Cerebral Angiography Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cerebral Angiography Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cerebral Angiography Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AngioDynamics, Inc.
14.1.3. B. Braun Melsungen AG
14.1.4. Becton, Dickinson and Company
14.1.5. Boston Scientific Corporation
14.1.6. Canon Medical Systems Corporation
14.1.7. Cardinal Health, Inc.
14.1.8. Carestream Health, Inc.
14.1.9. Cook Group Incorporated
14.1.10. GE Healthcare Technologies Inc.
14.1.11. Hitachi Medical Corporation
14.1.12. Hologic, Inc.
14.1.13. InterMed Medical Limited
14.1.14. Koninklijke Philips N.V.
14.1.15. MEDTRON AG
14.1.16. Medtronic PLC
14.1.17. Merit Medical Systems, Inc.
14.1.18. MicroPort Scientific Corporation
14.1.19. Penumbra, Inc.
14.1.20. Samsung Medison Co., Ltd.
14.1.21. Shimadzu Corporation
14.1.22. Siemens Healthineers company
14.1.23. St. Stone Medical Devices Private Limited
14.1.24. Stryker Corporation
14.1.25. Terumo Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. CEREBRAL ANGIOGRAPHY MARKET RESEARCH PROCESS
FIGURE 2. CEREBRAL ANGIOGRAPHY MARKET SIZE, 2023 VS 2030
FIGURE 3. CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CEREBRAL ANGIOGRAPHY MARKET DYNAMICS
FIGURE 7. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings